Prof Gordon McVie of ecancer and European Institute of Oncology, Milan, Italy talks about the new rules to the clinical trials framework whereby pharmaceutical companies and academic researchers will have to post the results of all their European clinical trials in a publicly-accessible database. Prof McVie discusses the benefits that this will bring and what ecancermedicalscience will do to support this new rule which could come into effect in 2016.

For the news article, please click here.

To read our recent research article on how cancer patients engage with clinical trials, please click here.